The impact of AMIGO2 on prognosis and hepatic metastasis in gastric cancer patients

The impact of AMIGO2 on prognosis and hepatic metastasis in gastric cancer patients

Abstract Background Gastric cancer (GC) is one of the most common malignancies, and the liver is the most common site of hematogenous metastasis of GC. AMIGO2 is a type I transmembrane protein that has been implicated in tumour cell adhesion in adenocarcinomas; however, its importance in GC remains...

Full description

Bibliographic Details
Main Authors: Keisuke Goto, Masaki Morimoto, Mitsuhiko Osaki, Akimitsu Tanio, Runa Izutsu, Yoshiyuki Fujiwara, Futoshi Okada
Format: Article
Language:English
Published: BMC 2022-03-01
Series:BMC Cancer
Subjects:
AMIGO2
AMIGO
Gastric cancer
Hepatic metastasis
Online Access:https://doi.org/10.1186/s12885-022-09339-0

Similar Items

Similar Items